HCA
HCA Healthcare, Inc. · Healthcare · Medical - Care Facilities
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q2 2024
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 163 | -3 | 97.84M | $38.18B | +4 | −7 |
| Q1 2026 | 169 | +3 | 106.88M | $50.54B | +5 | −3 |
| Q4 2025 | 165 | -1 | 114.61M | $53.42B | +1 | −1 |
| Q3 2025 | 26 | +1 | 64.51M | $27.48B | +1 | −1 |
| Q2 2025 | 23 | +1 | 60.26M | $23.08B | +1 | — |
| Q1 2025 | 19 | -2 | 30.59M | $10.56B | +1 | −3 |
| Q4 2024 | 21 | 0 | 31.21M | $9.36B | +1 | −1 |
| Q3 2024 | 20 | -1 | 22.69M | $9.21B | +1 | −2 |
| Q2 2024 | 21 | — | 27.53M | $8.84B | — | — |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 10.78M | — | $3.46B | 0.6% | n/c | 1 | SEC ↗ |
| 2 | Wellington Management ✦ | 10.78M | — | $3.46B | 0.6% | n/c | 1 | SEC ↗ |
| 3 | Wellington Management ✦ | 10.78M | — | $3.46B | 0.6% | n/c | 1 | SEC ↗ |
| 4 | Wellington Management ✦ | 10.78M | — | $3.46B | 0.6% | n/c | 1 | SEC ↗ |
| 5 | Wellington Management ✦ | 10.78M | — | $3.46B | 0.6% | n/c | 1 | SEC ↗ |
| 6 | Wellington Management ✦ | 10.78M | — | $3.46B | 0.6% | n/c | 1 | SEC ↗ |
| 7 | Wellington Management ✦ | 10.78M | — | $3.46B | 0.6% | n/c | 1 | SEC ↗ |
| 8 | Wellington Management ✦ | 10.78M | — | $3.46B | 0.6% | n/c | 1 | SEC ↗ |
| 9 | Wellington Management ✦ | 10.78M | — | $3.46B | 0.6% | n/c | 1 | SEC ↗ |
| 10 | Geode Capital Management ✦ (pasif) | 3.90M | — | $1.25B | 0.1% | n/c | 1 | SEC ↗ |
| 11 | Geode Capital Management ✦ (pasif) | 3.90M | — | $1.25B | 0.1% | n/c | 1 | SEC ↗ |
| 12 | Capital World Investors ✦ | 2.89M | — | $927.54M | 0.2% | n/c | 1 | SEC ↗ |
| 13 | Norges Bank ✦ (pasif) | 2.87M | — | $921.91M | 0.1% | n/c | 1 | SEC ↗ |
| 14 | Arrowstreet Capital ✦ | 2.52M | — | $809.99M | 0.7% | n/c | 1 | SEC ↗ |
| 15 | T. Rowe Price ✦ | 2.39M | — | $769.11M | 0.1% | n/c | 1 | SEC ↗ |
| 16 | T. Rowe Price ✦ | 2.39M | — | $769.11M | 0.1% | n/c | 1 | SEC ↗ |
| 17 | Viking Global Investors ✦ | 654.17K | — | $210.17M | 0.8% | n/c | 1 | SEC ↗ |
| 18 | Harris Associates (Oakmark) ✦ | 372.01K | — | $119.52M | 0.2% | n/c | 1 | SEC ↗ |
| 19 | Bridgewater Associates ✦ | 295.90K | — | $95.07M | 0.5% | n/c | 1 | SEC ↗ |
| 20 | Millennium Management ✦ | 252.72K | — | $81.19M | 0.1% | n/c | 1 | SEC ↗ |
| 21 | Glenview Capital ✦ | 195.59K | — | $62.84M | 1.3% | n/c | 1 | SEC ↗ |
| 22 | Adage Capital Partners ✦ | 142.61K | — | $45.82M | 0.1% | n/c | 1 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 71.82K | — | $23.07M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 71.82K | — | $23.07M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | AQR Capital Management ✦ | 71.82K | — | $23.07M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Citadel Advisors ✦ | 50.64K | — | $16.27M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Citadel Advisors ✦ | 50.64K | — | $16.27M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | GAMCO Investors ✦ | 38.23K | — | $12.28M | 0.1% | n/c | 1 | SEC ↗ |
| 29 | Markel Group ✦ | 35.10K | — | $11.28M | 0.1% | n/c | 1 | SEC ↗ |
| 30 | D. E. Shaw & Co. ✦ | 27.46K | — | $8.82M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | D. E. Shaw & Co. ✦ | 27.46K | — | $8.82M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | Gotham Asset Management ✦ | 22.11K | — | $7.10M | 0.1% | n/c | 1 | SEC ↗ |
| 33 | Renaissance Technologies ✦ | 12.80K | — | $4.11M | 0.0% | n/c | 1 | SEC ↗ |
| 34 | Marshall Wace ✦ | 1.60K | — | $514,048 | 0.0% | n/c | 1 | SEC ↗ |
| 35 | Fisher Asset Management ✦ | 783 | — | $251,815 | 0.0% | n/c | 1 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Tidak ada pembeli terlacak baru kuartal ini. |
Telah keluar
| Tidak ada keluar yang terlacak kuartal ini. |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 1 pemegang, 700 saham, $331 dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.